Objectives of the meeting
The application of statistics in Chemistry, Manufacturing & Control (CMC) to advance the development and commercialization of important medical products has tremendous impact. New statistical methods and digital and computing technologies are continuously emerging and must often be adapted to add value in the CMC context. Successful practitioners of CMC statistics come from a range of original disciplines, including formal training in statistics, mathematics, and many branches of science and engineering. This conference provides a forum for discussing recent advances and opportunities including Bayesian methods, artificial intelligence & machine learning, and deeper collaboration between clinical & CMC statisticians.
Scientific Committee
- Julia O'Neill Co-Chair; Moderna
- Kristi Griffiths Co-Chair; Eli Lilly and Company
- Stan Altan Johnson & Johnson
- Timo Bailer Boehringer Ingelheim
- Rick Burdick Burdick Statistical Consulting, LLC
- Cristiana Campa GlaxoSmithKline
- Catherine Cheng Novartis
- Joann Coleman Spark Therapeutics, Inc.
- Jun Gao Health Canada
- Katherine Giacoletti Merck & Co., Inc
- Theo Koulis Genentech
- Ruojia Li Bristol Myers Squibb
- Jia Liu Pfizer
- Charles Miller Merck & Co., Inc
- Guillermo Miro-Quesada AstraZenca
- John Oleynick Janssen
- Laura Pack Rezolute
- José Ramírez Kite Pharma
- Tim Schofield IABS